Antibiotics Industry – Current Status and Outlook by 2020

Antibiotics represent a major category of human and animal health products produced by fermentation and biotechnology. Principal antibiotic categories include: penicillin’s, cephalosporins, macrolides, aminoglycosides and teracyclines. Many antibiotics are available as therapeutics ‘as-is’ [e.g. penicillin V] and can be transformed to semi-synthetic derivates [e.g. amoxicillin via 6-APA]. Within the past years considerable research efforts have been devoted to developing novel antibiotics that can combat life-threatening infections such as MRSA [methicillin-resistant staphylococcus aureus] and several novel antibiotics have appeared in the market.

The following aspects of the antibiotic business are reviewed:

• output of all antibiotics and semi-synthetic derivates
• price levels of antibiotics
• profiles of antibiotic producers
• current manufacturing costs of various antibiotics and semi-synthetic derivates and how they compare with sales prices
• projected market for antibiotics and outlook by 2020

Click here to contact us for further information.

What's New

Yeast ß-Glucans in Sports Medicine ß-glucans are polysaccharides linked by glycosidic bonds which occur in cell walls from bak.....

read more»»

Genetically modified wheat Many cereals especially wheat are often infested with insects such as sap-sucking aphids. Farmers t.....

read more»»

Protein for Sports Nutrition This is the era of proteins, especially soya proteins. These were launched over 60 years ago by U......

read more»»

A Tale of Two Monoclonal Antibodies A major problem has arisen regarding two monoclonal antibodies Lucentis [ranibizumab] and Avastin [.....

read more»»

Have your Antimicrobial – and eat it Preservatives prevent the microbial spoilage of foods especially meats by preventing the growth of o.....

read more»»

Contact Info

L. Hepner & Associates
48 Portland Place, London W1B 1NG,
United Kingdom
phone: +44 20 7631 3194